Beta blockers and the elderly with glaucoma: are we adding insult to injury?
E O'Donoghue - The British Journal of Ophthalmology, 1995 - ncbi.nlm.nih.gov
Many elderly people tend not to complain in the face of often serious disease but stoically
accept'every tatter in their mortal dress'l as the inevitable price of aging. We, their carers …
accept'every tatter in their mortal dress'l as the inevitable price of aging. We, their carers …
β Blockers for glaucoma and excess risk of airways obstruction: population based cohort study
JF Kirwan, JA Nightingale, C Bunce, R Wormald - BMJ, 2002 - bmj.com
Topical β blockers are the most commonly prescribed drugs in the United Kingdom for
glaucoma. 1 They are known to exacerbate bronchospasm in asthma and chronic …
glaucoma. 1 They are known to exacerbate bronchospasm in asthma and chronic …
Should β blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy
I Goldberg - British journal of ophthalmology, 2002 - bjo.bmj.com
Br J Ophthalmol: first published as 10.1136/bjo. 86.6. 691 on 1 June 2002. Downloaded
from more potent than dipivefrin and less likely to provoke surface discomfort or allergic …
from more potent than dipivefrin and less likely to provoke surface discomfort or allergic …
Should [beta] blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 2.(Debate: Controversies in Ophthalmology)
GL Skuta - British Journal of Ophthalmology, 2002 - go.gale.com
Even with the availability of these newer agents, we believe that [beta] blockers, which have
been a mainstay of medical glaucoma management for over 20 years for many very good …
been a mainstay of medical glaucoma management for over 20 years for many very good …
Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma
P Diggory, A Cassels-Brown, A Vail… - British journal of …, 1998 - bjo.bmj.com
AIM To investigate respiratory and cardiovascular side effects in elderly people in the first 12
months after commencing topical β antagonists. METHODS 40 patients (mean age 74 years) …
months after commencing topical β antagonists. METHODS 40 patients (mean age 74 years) …
Glaucoma: systemic side effects of topical medical therapy—a common and under recognized problem
P Diggory, W Franks - Journal of the Royal Society of …, 1994 - journals.sagepub.com
Chronic open angle glaucoma is asymptomatic and generally detected by optometrists. It is
increasingly common with age affecting about 5% of those over 65 and is responsible for …
increasingly common with age affecting about 5% of those over 65 and is responsible for …
Should [beta] blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 1.(Debate: Controversies in Ophthalmology)
A Anton - British Journal of Ophthalmology, 2002 - go.gale.com
As a result of our use of [beta] blockers as initial therapy for glaucoma for several decades,
we have acquired extensive knowledge about their advantages and limitations.[beta] …
we have acquired extensive knowledge about their advantages and limitations.[beta] …
[引用][C] What's in a name? New glaucoma drugs
A Spratt, L Ogunbowale, R Wormald, W Franks - The Lancet, 2006 - thelancet.com
Ophthalmic use of topical β blockers to reduce the intraocular pressure in glaucoma patients
remains common practice, despite concerns about cardiovascular and respiratory side …
remains common practice, despite concerns about cardiovascular and respiratory side …
The safety of topical ß‐blockers in glaucoma treatment
I Goldberg - Medical journal of Australia, 1996 - Wiley Online Library
The safety of topical à ╒blockers in glaucoma treatment Page 1 Clinical Practice The safety of
topical B-blockers in glaucoma treatment Ivan Goldberg While adverse effects are uncommon …
topical B-blockers in glaucoma treatment Ivan Goldberg While adverse effects are uncommon …
Do selective topical β antagonists for glaucoma have respiratory side effects?
JF Kirwan, JA Nightingale, C Bunce… - British journal of …, 2004 - bjo.bmj.com
Background/aims: Topical β antagonists are prescribed for glaucoma in approximately 500
000 people in the United Kingdom. The authors have previously shown that topical β …
000 people in the United Kingdom. The authors have previously shown that topical β …